ICU Medical Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de ICU Medical de 52% y 2.3% por año respectivamente. Se prevé que el BPA crezca en un 52.1% al año. Se espera que la rentabilidad financiera sea de 4.2% en 3 años.

Información clave

59.2%

Tasa de crecimiento de los beneficios

61.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.6%
Tasa de crecimiento de los ingresos	2.5%
Rentabilidad financiera futura	4.7%
Cobertura de analistas	Low
Última actualización	09 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 23

Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts

Jan 28

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Dec 05

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Nov 04

ICU Medical: Decisive M&A, Again

Sep 10

Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?

Sep 05

Some Investors May Be Worried About ICU Medical's (NASDAQ:ICUI) Returns On Capital

Jul 30

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:ICUI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	2,389	82	N/A	348	1
12/31/2025	2,374	41	N/A	322	5
12/31/2024	2,287	-71	N/A	165	5
3/31/2024	2,257	-59	75	171	N/A
12/31/2023	2,259	-30	73	166	N/A
9/30/2023	2,249	-28	-13	73	N/A
6/30/2023	2,294	-48	-44	40	N/A
3/31/2023	2,306	-46	-110	-20	N/A
12/31/2022	2,280	-74	-161	-62	N/A
9/30/2022	2,043	-39	-78	22	N/A
6/30/2022	1,781	5	-1	99	N/A
3/31/2022	1,541	41	124	215	N/A
12/31/2021	1,316	103	186	268	N/A
9/30/2021	1,296	109	175	263	N/A
6/30/2021	1,279	103	168	260	N/A
3/31/2021	1,260	94	146	235	N/A
12/31/2020	1,271	87	122	223	N/A
9/30/2020	1,266	81	98	193	N/A
6/30/2020	1,255	83	73	168	N/A
3/31/2020	1,264	87	60	162	N/A
12/31/2019	1,266	101	-4	102	N/A
9/30/2019	1,291	73	3	103	N/A
6/30/2019	1,311	47	1	104	N/A
3/31/2019	1,359	55	57	160	N/A
12/31/2018	1,400	29	59	160	N/A
9/30/2018	1,430	86	90	195	N/A
6/30/2018	1,446	86	140	242	N/A
3/31/2018	1,417	18	119	210	N/A
12/31/2017	1,293	69	N/A	154	N/A
9/30/2017	1,018	28	N/A	91	N/A
6/30/2017	772	47	N/A	19	N/A
3/31/2017	537	101	N/A	-4	N/A
12/31/2016	379	63	N/A	90	N/A
9/30/2016	372	59	N/A	84	N/A
6/30/2016	361	56	N/A	77	N/A
3/31/2016	348	53	N/A	68	N/A
12/31/2015	340	45	N/A	64	N/A
9/30/2015	329	47	N/A	61	N/A
6/30/2015	321	37	N/A	61	N/A
3/31/2015	316	29	N/A	61	N/A
12/31/2014	307	26	N/A	66	N/A
9/30/2014	306	32	N/A	72	N/A
6/30/2014	311	37	N/A	69	N/A
3/31/2014	311	38	N/A	68	N/A
12/31/2013	312	40	N/A	66	N/A
9/30/2013	318	39	N/A	68	N/A
6/30/2013	317	41	N/A	61	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que ICUI sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que ICUI sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que ICUI sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (2.3% al año) de ICUI crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.3% al año) de ICUI crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de ICUI sea baja dentro de 3 años (4.2%).

ICU Medical Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 65%

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Price target decreased by 24% to US$154

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

Consensus EPS estimates fall by 326%

Recent updates

Consensus EPS estimates fall by 65%

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

ICU Medical, Inc., Annual General Meeting, May 15, 2024

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

CEO & Chairman of the Board exercised options and sold US$262k worth of stock

ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director

Director notifies of intention to sell stock

Chief Operating Officer recently sold US$1.5m worth of stock

ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Chairman of the Board exercised options and sold US$5.4m worth of stock

ICU Medical, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care (Sector)

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 24% to US$154

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

ICU Medical, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Chief Operating Officer recently sold US$884k worth of stock

Chief Operating Officer notifies of intention to sell stock

ICU Medical Inc. Receives FDA Clearance for Plum Duo Infusion Pump and LifeShield Infusion Safety Software

Icu Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q2, 2023 Results on Aug 07, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Now 23% undervalued after recent price drop

CEO & Chairman of the Board notifies of intention to sell stock

ICU Medical, Inc.(NasdaqGS:ICUI) dropped from Russell Small Cap Comp Growth Index

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

CEO & Chairman of the Board exercised options and sold US$3.9m worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Corporate VP notifies of intention to sell stock

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

CEO & Chairman of the Board exercised options and sold US$1.5m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc. to Report Q4, 2022 Results on Feb 27, 2023

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Corporate VP notifies of intention to sell stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

ICU Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2022

ICU Medical, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Director exercised options to buy US$12m worth of stock.

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Consensus EPS estimates fall by 326%

Price target decreased to US$221

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Consensus forecasts updated

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

ICU Medical, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Consensus EPS estimates fall by 18%

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 50%

Corporate VP recently sold US$130k worth of stock

Now 21% undervalued after recent price drop

First quarter 2022 earnings: EPS and revenues miss analyst expectations

ICU Medical, Inc. to Report Q1, 2022 Results on May 09, 2022

ICU Medical, Inc., Annual General Meeting, May 17, 2022

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

CEO & Chairman of the Board exercised options and sold US$411k worth of stock

CEO & Chairman of the Board exercised options and sold US$6.5m worth of stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind